INTRODUCTION
A key step of each IVF cycle is the selection of an embryo with the highest implantation and developmental potential (Ebner et al., 2003) . Nevertheless, transfer of an embryo with a good morphology does not necessarily lead to its implantation (El-Danasouri et al., 2016) , because it was shown that chromosomal aneuploidy frequently leads to implantation failure or early miscarriage (Forman et al., 2012; Dahdouh et al., 2015) . Some chromosomal aneuploidies affect the embryonic development already in its early stages, causing developmental arrest and irregular cell division (Minasi et al., 2016) . In spite of this, it seems impossible to detect aneuploidies only by assessing embryo morphology (Davies et al., 2012; Coates et al., 2015) .
Although aneuploid embryos might undergo self-correction during their preimplantation stages of development (Li et al., 2005; Barbash-Hazan et al., 2009) , the prevalence of persisting chromosomal abnormalities in trophectoderm biopsies remains high even in embryos derived from donor eggs. Statistically, the number of aneuploid embryos based on trophectoderm biopsy analysis ranges from 18-61% in egg donation cycles (Munné et al., 2017) . Aneuploidy rates in embryos are increasing with maternal age (Franasiak et al., 2014; Demko et al., 2016) . Most aneuploidies have been shown to originate from maternal meiotic errors. Rabinowitz et al. (2012) observed in blastomeres that chromosome trisomies of maternal origin are almost 10 times more common than trisomies of paternal origin. Similar results were obtained by the analysis of trophectoderm biopsies (McCoy et al., 2015) . Moreover, a polar body study, including corresponding zygotes, indicates that errors in meiosis II (MII) are more frequent than in meiosis I (MI). It is clear that, with 45% of aneuploidies originating in maternal MII and with 34% of aneuploidies originating in maternal MI, maternal meiosis errors are the main cause of whole chromosomal aneuploidy in human embryos (Handyside and Montag, 2012) . Some errors described as MII errors, based only on copy number variation (CNV) analysis of the polar bodies, however, could be considered as MI errors owing to a newly described reverse segregation pattern (Ottolini et al., 2015) . The incidence of segmental aneuploidies has been reported to be 10.4% in oocytes, with a dramatic increase to 24.3% during the first 3 days of embryonic development, before starting to decline to 15.6% as the embryos reach the blastocyst stage (Babariya et al., 2017) .
Chromosomal aneuploidies are a significant cause of implantation failure or pregnancy loss, especially in older women (Kroon et al., 2011; Harton et al., 2013) . Hence, much effort has been made to introduce novel approaches to achieve a reliable detection of chromosomal abnormalities. Over the years, technology has evolved rapidly, and comprehensive chromosome screening (CCS) has become widely used worldwide (Handyside, 2013) . Although metaphase comparative genomic hybridization (CGH) was the first method used for CCS (Voullaire et al., 1999; Wells et al., 1999) , other technologies are available for 24-chromosome copy number analysis, including arrayCGH (Gutiérrez-Mateo et al., 2011) , digital polymerase chain reaction (PCR) (Daser et al., 2006) , quantitative real-time PCR and next-generation sequencing (Fiorentino et al., 2014) . All the above-mentioned methods, however, are unable to distinguish whether aneuploidy is of maternal or paternal origin.
The origin of aneuploidy can be determined via single nucleotide polymorphism (SNP) array testing provided that DNA samples from both parents are also analysed together with the tested embryos (Rabinowitz et al., 2012) . Karyomapping, a SNP microarraybased method, supplies us with even more information and a deeper insight (Handyside et al., 2010) . A karyomap of all chromosomes is established by genotyping the parents, a close relative with a known disease status and the examined embryo. Genotyping both the parents and the embryos at the same time allows us to distinguish the parental origins of each chromosome and to identify the position of each chromosomal crossing-over. Moreover, karyomapping supports copy number calling and, therefore, is a powerful tool for detecting a variety of chromosomal abnormalities. Together, these provide comprehensive information about the incidence and origins of chromosomal abnormalities in embryos.
Karyomapping not only combines CCS and preimplantation genetic testing of monogenic disease (PGT-M) (Natesan et al., 2014a) , but, in combination with a direct mutation analysis, is also suitable for detecting de-novo PGT-M cases (Giménez et al., 2015) .
The aim of this study was to demonstrate the utilization of SNP data by karyomapping for comprehensive chromosomal screening in parallel with PGT-M, and to present our finding on the frequency and origin of whole and segmental chromosomal abnormalities in almost 1000 IVF-derived embryos for a better and more comprehensive understanding of human aneuploidy.
MATERIALS AND METHODS

Participants
In this study, 180 couples underwent 215 cycles of PGT-M. They all gave informed consent to PGT-M by karyomapping. Ethical approval for this study was sought and a waiver was obtained on 27 March 2018 from the Ethical Commission for Assisted Reproduction Techniques and Preimplantation Genetic Diagnosis (IRB reference number: 022018). A total of 967 embryos were obtained for analysis, which resulted in an average of 5.4 (SD ± 1.84) trophectoderm biopsies per couple and 4.4 (±1.31) trophectoderm biopsies per cycle. The mean maternal age was 32.7 (±5.01) at the time of oocyte retrieval. The maternal age ranged from 20-46 years.
Embryo biopsy and whole-genome amplification
Laser-mediated trophectoderm biopsy of embryos was carried out on day 5 or 6 of embryo culture, depending on embryo development and morphology. Each biopsied embryo was subjected to assisted hatching on the first day of embryo culture to facilitate cell removal during the biopsy. On average, five to 10 cells were biopsied and subsequently transferred to sterile, DNA-and RNAfree polymerase chain reaction tubes. Each sample was then amplified using multiple displacement amplification (MDA) according to the manufacturer's manual (REPLI-g Single cell kit, Qiagen, Germany). Amplification success was checked on a 1% agarose/0.5 x trisborate-ethylenediaminetetraacetic acid for the presence of a DNA smear typically greater than 10 kb. Only samples with a visible and robust smear were used for the subsequent analysis.
Single nucleotide polymorphism genotyping
Amplified trophectoderm biopsies were genotyped using a genome-wide SNP genotyping with bead arrays (HumanKaryomap-12v1.0 BeadChip, Illumina Inc., USA) according to the manufacturer's manual. The maternal, paternal and reference DNA with a known disease status was also genotyped without any modification. A karyomapping analysis of the SNP data was performed by a karyomapping module in Bluefuse software (Bluefuse multi v4.2; Illumina Inc, USA).
Array comparative genomic hybridization reanalysis
A total of 42 MDA amplified trophectoderm samples scored as aneuploid and 18 MDA amplified trophectoderm samples from reciprocal translocation patients were reanalysed by V3 arrays (V3, Illumina, USA) as described previously (Hornak et al., 2014) with one modification. A total of 8 µl (125 ng/µl) MDA amplified DNA samples from individuals 46,XY and 46XX were used as control samples for aCGH.
Calling of chromosomal aneuploidies by array comparative genomic hybridization
Detection of aneuploidy in samples reanalysed by an array CGH from previously amplified DNA samples by MDA was based on the chromosome X-separation. Trisomy was called when a value for a given chromosome exceeded 0.55 x log2 ratio of the X-separation. Monosomy was called when -0.85 x log2 ratio of the X-separation was exceeded. These thresholds were set based on the internal validation of aneuploid cell lines analysed by aCGH.
Calling of chromosomal aneuploidies by karyomapping
Karyomapping provides a qualitative and quantitative detection of chromosomal abnormalities. The qualitative analysis is based on informative SNPs and the quantitative analysis is based on the Log-R ratio chart and the B-allele frequency (BAF) chart. All three parameters were analysed in each chromosome of all samples. An average 92.6% (±5.4) of SNPs were successfully analysed by BlueFuse Multi (so called 'call rate'). Chromosomal changes larger than 15Mb were considered as segmental losses or gains. Detection limit 15Mb was determined based on validation of embryos with a known reciprocal translocation where the smallest unbalanced product of this translocation was 15Mb. All segmental gains and losses corresponding to the reciprocal translocation from validation samples were independently evaluated by all parameters (Log-R, BAF and haploblocks).
Meiotic gains (triploid samples, meiotic trisomies and duplications) are characterized by the presence of both homologous chromosomes or chromosomal segments inherited from a single parent. The so-called 'both parental homologs' (BPH) trisomy and BPH segmental gain were called if they were indicated by all three parameters (BAF, LogR and haploblock charts) and call rate was over 60%. On the other hand, mitotic gains and meiotic trisomies without recombination are characterized by the presence of an extra chromosome that is completely identical to another chromosome. These errors are known as the 'single parental homolog' (SPH) trisomy. These types of errors were excluded from this study because they were not visible on a haploblock chart. Mitotic gains are difficult to detect only by Log-R and BAF in trophectoderm biopsies, particularly when the call rate is below 90%.
Moreover, in meiotic errors with a BPH pattern, MI and MII errors were categorized. Errors occurring during the first meiotic division were identified by the presence of BPH in the pericentromeric region. In other words, both non-sister pericentromeric regions from one parent were present in the embryo. Reversely, two sister pericentromeric regions from one parent identified by a single parental haplotype indicated MII errors. In this case, BPH occurred after the formation of the first crossing-over.
Monosomies, segmental losses and haploid samples were called when indicated by BAF, Log-R and haploblock charts in embryos with a call rate over 60%. Unlike trisomies, in which the BPH pattern clearly indicates meiotic errors, monosomies determined to be of meiotic origin should be taken with some caution owing to a possible mitotic origin. The loss of a chromosome could have occurred either during meiosis or after the zygote phase, whereas the results on karyomapping would be identical depending on the chromosomal constitution of biopsied cells (further commented in the Discussion section). A chromosomal loss identified only via BAF and LogR charts but not visible by a haploblock chart at the same time indicated a mosaic monosomy, or a segmental loss in mosaic. This type of error was excluded from the results table. Only segmental losses in mosaic with a call rate over 95% are reported as supportive findings for parental origin of segmentals. Detection of this segmental mosaic loss, however, is not validated. A thorough analysis of raw SNP data by Excel Macro was used to determine supportive parental origins of segmental loss in mosaic. Our Excel Marco filters all SNP where the parental constellation is maternal 'AA' and paternal 'BB' or vice versa. In that case, all embryos should have the 'AB' genotype. The population of AB genotypes is divided into two subpopulations AAB and ABB in mosaic monosomies and SPH trisomies. Analysis of these SNPs enables us to determine the parental origin.
Breakpoint analysis
To achieve accurate breakpoint detection by karyomapping, 18 embryos obtained from two couples of which each woman was the carrier of reciprocal translocation were analysed using haploblock charts. The position of the breakpoint was defined as an arithmetical mean between the position of the last informative SNP before the break and a position of the first informative SNP after the chromosomal break.
Statistical analysis
GraphPad Prism (San Diego, USA, version 6) was used for statistical analysis. The binomial test was used in the case of two possible outcomes (maternal/ paternal; MI/MII). A two-tailed Fisher`s exact test was calculated for aneuploidy comparison of two or more groups, e.g. monosomy/trisomy, groups based on parental age.
RESULTS
The ability of karyomapping to detect different types of chromosomal abnormalities To compare aneuploidy detection by karyomapping and arrayCGH, 31 trophectoderm biopsy samples scored as aneuploid or mosaic by karyomapping were reanalysed by arrayCGH ( Supplementary TABLE) . To exclude biological differences by repeated sampling of one embryo, MDA-amplified DNA from a primary sample previously analysed by karyomapping was used for arrayCGH reanalysis. All chromosomal aneuploidies indicated by BAF, LogR and haploblock charts by karyomapping presumed to be of meiotic origin (27 whole chromosomal aneuploidies and three segmental chromosomal losses) were also detected by arrayCGH. In one case, the arrayCGH detected a segmental chromosomal gain presumed to be mitotic gain that was indicated by karyomapping analysis only via Log-R chart, but not BAF and haploblock charts.
Furthermore, to test consistency and accuracy of karyomapping in order to detect segmental gains and losses, we reanalysed 18 trophectoderm samples from two couples in which female partners were carriers of reciprocal translocation 46,XX,t(11;22)(q23.3;q11.2) and 46,XX,t(9;12)(q21.34;q21.32), respectively. Unbalanced segregations of the translocated chromosomes during meiosis were detected in 13 out of 18 embryos (eight of them were segmental abnormalities corresponding to translocated chromosome parts and five were whole chromosome aneuploidies of chromosomes involved in translocation). In all cases, reanalysis by arrayCGH confirmed karyomapping findings. In seven embryos from one couple and one embryo from another couple in which segmental imbalances were identified, a breakpoint analysis was conducted (FIGURE 1).
Distribution of different chromosomal abnormalities (aneuploidies) in embryos
Karyomapping enables the detection of various meiotic chromosomal abnormalities, including whole chromosomal and segmental aneuploidies. A total of 967 trophectoderm biopsies obtained from 180 couples with a mean maternal age of 32.7 years were analysed. Out of these, more than 97% (n = 945/967) of trophectoderm biopsies were successfully analysed. Our results show that 31.0% (n = 293/945) of these trophectoderm biopsies were aneuploid. At least one whole chromosomal aneuploidy was detected in 27.1% (n = 256/945) of the embryos and at least one segmental aneuploidy in 5.1% (n = 48/945) of the embryos. Both whole chromosomal and segmental aneuploidy were detected in 1.2% (n = 11/945) samples.
Most of the aneuploid embryos contained a single aneuploidy. Embryos with a single monosomy (39.2%; n = 115/293; P < 0.05) were detected twice as often as embryos with a single trisomy (18.4%; n = 54/293). Two aneuploidies were detected in 20.1% (n = 59/293) and three or more aneuploidies in 15% (n = 44/293) of these embryos. After exclusion of 14 rare chromosomal abnormalities, of the remaining 408 chromosomal abnormalities detected by karyomapping, 354 (86.8%) were whole chromosomal aneuploidies and 54 (13.2%) segmental aneuploidies.
Rare chromosomal abnormalities, such as uniparental disomy (UPD), haploidy and meiotic triploidies, were also detected among the successfully analysed embryos (n = 945). A haploid embryo with only the maternal chromosome set was detected twice (0.2%) and a triploid embryo was detected nine times (1%). Out of these, digynic triploidy was detected seven times (0.7%) and diandric triploidy twice (0.2%). Moreover, three (0.3%) UPD, including two (0.2%) heterodisomies and one (0.1%) isodisomy, were detected (Supplementary FIGURE) .
Characterization of aneuploidies detected by karyomapping
Individual aneuploidies were analysed in detail to categorize them further according to their maternal or paternal origin (TABLE 1). The most striking difference was observed for the parental origin of whole chromosomal and segmental aneuploidies. Although whole chromosomal aneuploidies affect mainly maternal chromosomes (n = 319/354; 90.1%; P < 0.0001), segmental aneuploidies affect paternal chromosomes (n = 38/54; 70.4%; P < 0.01). Even though aneuploidies believed to be of mitotic origin were detected in this cohort of embryos, they were excluded from the final results presented in the study because of concerns about the ability of karyomapping to detect mosaic abnormalities accurately as a standalone method. It was still interesting, however, that, of the 30-presumed mosaic segmental abnormalities detected, 23 (76.7%) were detected on the paternal chromosomes after thorough analysis of SNP data.
In contrast to frequent maternal meiotic errors, indicated by BPH trisomies (91.9%), paternal meiotic errors are rare (8.1%). Moreover, errors in meiosis I (MI) and meiosis II (MII) were distinguished in BPH trisomies based on the distribution of informative SNPs in the pericentromeric regions. More than two-thirds (69.4%; P < 0.0001) of meiotic errors were caused by MI errors and less than one-third (30.6%) by MII errors. Two BPH trisomies were inconclusive. This difference was even higher (71.9% versus 28.1%) in cases in which only maternal BPH trisomies were included. Because the paternal BPH signature was detected only in 12 cases, it is hard to say whether the MI versus MII error rate difference (41.7% versus 58.3%) is biased by a small data set or reflects a different mechanism which underlines error origin in male meiosis compared with females.
Relationship between parental age and incidence of whole and segmental aneuploidies
Unlike whole chromosomal aneuploidies, which are increasing with maternal age, no relationship was observed between maternal age and the incidence of segmental aneuploidy. The prevalence of embryos with whole chromosomal aneuploidy was 23% (152/662) in the group of women under the age of 35 years compared with 49.8% (n = 141/283; P < 0.0001) in the group of women over the age of 35 years. The proportion of embryos with segmental aneuploidy was 5.9% (39/662) in women under the age of 35 years and 5.3% (15/283) in older women. No association was observed between the paternal age and whole chromosomal (P = 0.89) or segmental aneuploidy (P = 0.23). The breakdown of paternal age was under 35 years (n = 453), 35-45 years (n = 270) and over 45 years (n = 222), where 'n' stands for the amount of analysed embryos in these groups.
DISCUSSION
In the present study, we analysed 967 trophectoderm biopsies from 180 couples with a mean maternal age of 32.7 years to demonstrate that karyomapping is a universal tool for PGT-M (Handyside et al., 2010; Natesan et al., 2014b; Konstantinidis et al., 2015) , and also identifies various types of chromosomal abnormalities and their nature in human IVF embryos. According to our results, 31.0% of all analysed trophectoderm samples were aneuploid. Therefore, our data show a lower aneuploidy frequency compared with the previously reported 45% in groups of women within a maternal age between 27 and 35 years who underwent CCS for all 24 chromosomes on trophectoderm biopsies (Demko et al., 2016) . Other studies of trophectoderm samples after CCS also reported a higher frequency of aneuploid embryos (44-56%) in a group of women with a mean maternal age ranging from 36-39 years (Fragouli and Wells, 2011; Adler et al., 2014; Mccoy et al., 2015) . These studies also confirm that aneuploidy rates rapidly increase in women aged 35 years and older (Demko et al., 2016) . In addition to this, aneuploidy rates distinctively fluctuate even in donors between various IVF centres (Munné et al., 2017) . Although maternal age plays a significant role in aneuploidy occurrence, other factors such as ovarian stimulation protocols, IVF and embryo culture might contribute to their incidence (Baart et al., 2007; Verpoest et al., 2008) . Two possible explanations for the lower aneuploidy frequency detected in our set of embryos include the following: first, our set of patients consisted of presumably fertile couples who underwent IVF cycles owing to the occurrence of a single gene disorder in their families. In combination with a lower mean maternal age within our group of patients, this would probably lead to a lower frequency of aneuploid embryos; second, the decrease in aneuploidy rate is the fact that karyomapping is not expected to detect all post-zygotic errors effectively, especially SPH mitotic gains and mosaic aneuploidies, that are indicated only by logR and BAF charts. This type of error was excluded from this study, and, therefore, the aneuploidy rate was underestimated compared with other platforms such as next-generation sequencing. A combination of the both above-mentioned factors probably causes a difference in the rates of detected aneuploidies among other studies.
The potential ability of karyomapping to detect post-zygotic errors needs to be addressed in further investigations. We noticed a number of aneuploidies detected only by Log R and BAF charts that indicated potential mosaic monosomies or SPH trisomies, including segmentals. These were excluded from the final results of this study because a validated method for detection of mosaic and mitotic abnormalities was not used in parallel. Karyomapping could potentially accurately detect a certain percentage of mosaic abnormalities but this needs to be further assessed in future studies. Mitotic SPH gains are especially difficult to detect via karyomapping owing to the noise in trophectoderm samples with a lower call rate. Our comparison of karyomapping and aCGH results, however, show 100% concordance for detection of meiotic aneuploidies, including segmental abnormalities owing to reciprocal translocation detection. Karyomapping can clearly determine trisomies of meiotic origin via the presence of the BPH pattern. When it comes to the detecting monosomies in the embryo, the determination of the meiotic origin should be taken with caution as this is only indirectly determined by presumed absence of one of the parents' haplotype in the biopsied sample. Use of a validated method with the ability to distinguish mosaic abnormalities, e.g. next-generation sequencing, in parallel to karyomapping, would help increase the confidence. The matter of correct representation of the embryo's chromosomal constitution by the biopsied sample, however, would always remain; for example, a biopsy of a mosaic monosomic embryo could by chance contain only cells affected by the monosomy and therefore, appear incorrectly as if the embryo is affected with an abnormality of meiotic origin. The transfer of mosaic embryos has a lower implantation rate, a higher miscarriage rate and a reduced chance of an ongoing pregnancy (Fragouli et al., 2017) . The interpretation of mosaicism and the decision whether to transfer mosaic embryos is a controversial topic without clear consensus in guidelines and recommendations to date. Therefore, the ability of karyomapping to detect primarily meiotic trisomies and monosomies might be seen as less controversial.
In assessing parental origins of whole chromosomal aneuploidies, our data confirmed a well-known fact that most chromosomal aneuploidies are of maternal origin (Nagaoka et al., 2012) . We observed that 90.1% of all whole chromosomal aneuploidies are caused by an additional or a missing maternal chromosome. That this does not necessarily mean that they are of maternal origin, however; post-zygotically occurring mitotic monosomies affecting maternal chromosomes might be also included. In our study, we detected that 91.9% of chromosomal gains with the BPH signature originated in oogenesis. Similar findings have previously been reported in blastomere (96.2%) and trophectoderm (94.6%) biopsies (McCoy et al., 2015) . A study focusing on the analysis of both polar bodies and the corresponding zygote revealed that almost 80% of all whole chromosomal aneuploidies are of maternal origin (Handyside and Montag, 2012) .
According to our data, the BPH signature in maternal meiotic gains was caused more frequently by MI errors (P < 0.0001). Our results are in line with a previously published study in which most trisomies, e.g. chromosomes 13, 15 and 21, of maternal origin were caused by errors occurring during MI (Chiang et al., 2012) . In both studies, similar criteria for MI and MII errors were used.
To determine whether the BPH signature originated from MI or MII errors, we focused on the pericentromeric regions. The BPH in the pericentromeric regions indicate that more than two-thirds of maternal meiotic trisomies originate in MI errors, based on the premise that homologous chromosomes separate during the MI division and sister chromatids during the MII division. On the other hand, more MII (57%) than MI (43%) errors were detected in a study in which aCGH was used to analyse CNV of first polar body (PB1) and second polar body (PB2), with an average maternal age of 40 years (Handyside and Montag, 2012) . Two explanations for this MI versus MII error ratio are possible. First, MII errors are increasing with maternal age. In our study, average maternal age was 32.7 years compared with 40 years. It was previously reported that premature separation of dyads in meiosis II was the major segregation defect in aged mice eggs (Yun et al., 2014) . These investigators have shown that, although considerable cohesion loss occurs during MI, its consequences are observed during MII, when centromeric cohesion is needed to maintain dyad integrity. This could be also caused by a second explanation that is newly described 'reverse segregation' pattern during MI (Ottolini et al., 2015) .
Apart from the canonical segregation, the second most frequent segregation pattern gives rise to a PB1 with two non-sister chromatids. Both the corresponding oocyte and the PB2 contained a nonsister chromatid instead of a sister chromatid. If reverse segregation occurs, karyomapping detects BPH and therefore classifies the error as MI. The same type of error, however, would not be visible in PB1 by CNV methods and therefore the error would be classified as MII. Our observation that MI errors are more frequent than MII errors is consistent with the reverse segregation pattern (Ottolini et al., 2015) . A question still remains whether this type of error can be defined as MI errors based on the deviation from the canonical segregation pattern or as MII errors based on the abnormal chromosome copy number in PB2.
In assessing BPH signature in paternal chromosomes, it seems that MI errors occur with a similar frequency as MII errors. Differences between male and female rates of MI and MII errors could be explained by different mechanisms underlying the error origin in male meiosis compared with female (Hunt and Hassold, 2002) . Another explanation could reflect differences in the duration of male and female meiosis. However, our finding might be biased due to the small number of paternal gains with the BPH signature in our data set. A further investigation is needed to confirm whether the rates of MI and MII errors differ between males and females.
The most striking observation in our study came with the discovery that segmental aneuploidies more frequently affect paternal chromosomes (P < 0.01), whereas whole chromosomal aneuploidies more often involve maternal chromosomes (P < 0.0001) in aneuploid embryos. To the best of our knowledge, we are the first to report that segmental changes in human preimplantation embryos affect mainly paternal chromosomes. It has been previously reported that the incidence of segemntal errors is varying between oocytes (10.4%), blastomeres (24.3%) and trophectoderm biopsies (15.6%) with most segmentals seemed to arise during the first few mitoses after fertilization (Babariya et al., 2017) . Compared with this study, our results underestimate trophectoderm biopsies with segmental aneuploidy (5.1%), but this is expected as this study only focused on segmental aneuploidies of meiotic origin. This is consistent with the claim that most of the segmentals are of mitotic origin. Moreover, a thorough analysis of the excluded segmental aneuploidies indicated only by LogR and BAF (most likely segmental aneuploidy in mosaic) revealed that this type of finding also predominantly affected paternal chromosomes. A proper validation, however, for mitotic and mosaic aneuploidies is lacking in this study and confirmation that mitotic segmentals also affect predominantly paternal chromosomes is needed.
Unlike whole chromosomal aneuploidies, which mainly affects maternal chromosomes and show a strong association with an advancing maternal age (Demko et al., 2016) , no relationship was observed between neither the maternal nor the paternal age and the incidence of segmental abnormalities. Altogether, this suggests that the molecular processes leading to segmental aneuploidy differs from those responsible for whole chromosomal aneuploidy. We speculate that DNA fragmentation during spermatogenesis might be the main reason why most of the segmental changes affect paternal chromosomes and could partially explain the prevalence of meiotic segmental losses compared with segmental gains. Unrepaired fragments may be lost either during fertilization or during the first cell divisions in the early embryonic development resulting in segmental loss. It was previously shown that a certain level of DNA fragmentation (<30%) is common even in fertile men, depending on the method used for analysis (Schulte et al., 2010) . Furthermore, it was observed that topoisomerase induced double-strand DNA breaks are necessary for proper nucleohistonenucleoprotamine transition (Francis et al., 2014) . About 4.8-9.5% of the human genome show benign CNV among healthy individuals (Zarrei et al., 2015) . Sequence analysis of multiple DNA de-novo CNVs revealed that multiple breakpoints united maternal and paternal sequences, indicating that these rearrangements arose after fertilization (Voet and Vermeesch, 2017) . It remains to be determined whether these chromosomal changes occur solely in preimplantation embryos or also during gametogenesis.
Karyomapping can also detect rare chromosomal abnormalities, such as UPD, that would remain undetected by methods based only on CNV analysis. The UPD was detected three times (0.32%) among the tested embryos. Our findings correspond with the previously reported low prevalence of UPD in blastomeres (3.6%; 10/274) (Rabinowitz et al., 2012) , trophectoderm biopsies (0.06%; n = 2/3401) (Gueye et al., 2014) , pregnancy losses (0.38%; n = 7/1861) (Levy et al., 2014) and newborns (Robinson, 2000) . In all three embryos with UPD, we also detected other chromosomal abnormalities. Therefore, these embryos would not be considered for embryo transfer even if the UPD remained undetected. The low prevalence of UPD in blastocysts supports the fact that embryo self-correction via trisomy or monosomy rescue mechanisms is rare. Furthermore, our findings support the proposal that methodologies of CCS should not necessarily be limited to those that are capable of UPD detection (Gueye et al., 2014) .
Apart from UPD we also detected that 1% of the successfully analysed embryos were triploid and 0.2% haploid. Although various platforms are used for detection of triploidy (aCGH, qPCR, next-generation sequencing and SNP array) differences exist in the capabilities of each of these technologies. Currently, only karyomapping and SNP arrays with a bioinformatic approach can detect triploidy and haploidy with parental origin. Our data are in agreement with the previously estimated 1-1.5% of triploid and less than 1% of haploid trophectoderm samples analysed by SNP array (McCoy et al., 2015; Doody et al., 2016) . We similarly detected that most of the triploid samples are of maternal origin. Triploidy may occur as a result of normal fertilization of a diploid oocyte, dispermic fertilization of a normal haploid oocyte or fertilization by a diploid sperm. Because of routine use of intracytoplasmic sperm injection in our IVF programme dispermic fertilization can be ruled out. Triploidy typically results in first-trimester miscarriage or second-trimester fetal death and haploid samples fail to implant (Levy et al., 2014; Maxwell et al., 2016) . Therefore, detection of triploidy and haploidy is crucial for the increasing implantation rate and reducing the miscarriage rate after embryo transfer.
In our study, we have demonstrated that karyomapping is a universal method for PGT-M and also a robust tool for detecting meiotic errors. Moreover, combining a quantitative and a qualitative analysis of SNPs provides a powerful method that uncovers the parental origin and the nature of chromosomal abnormalities, although the ability to detect mitotic errors remains to be determined. The combination of these two approaches reveals that segmental chromosomal changes affect significantly more often paternal chromosomes than whole chromosomal aneuploidies. Categorization of the type and origin of chromosomal abnormalities by karyomapping provides us with enhanced prognostic information that is useful for directing a more personalized patient management approach involving such an important decision whether egg or sperm donation should be considered.
